![Leveraging external data in the design and analysis of clinical trials in neuro-oncology - The Lancet Oncology Leveraging external data in the design and analysis of clinical trials in neuro-oncology - The Lancet Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/081014da-0892-4d75-8378-d5f9c963f700/gr1_lrg.jpg)
Leveraging external data in the design and analysis of clinical trials in neuro-oncology - The Lancet Oncology
![Reimagining patient-centric cancer clinical trials: a multi-stakeholder international coalition | Nature Medicine Reimagining patient-centric cancer clinical trials: a multi-stakeholder international coalition | Nature Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41591-022-01775-6/MediaObjects/41591_2022_1775_Fig1_HTML.png)
Reimagining patient-centric cancer clinical trials: a multi-stakeholder international coalition | Nature Medicine
![Testing for carryover effects after cessation of treatments: a design approach | BMC Medical Research Methodology | Full Text Testing for carryover effects after cessation of treatments: a design approach | BMC Medical Research Methodology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12874-016-0191-6/MediaObjects/12874_2016_191_Fig2_HTML.gif)
Testing for carryover effects after cessation of treatments: a design approach | BMC Medical Research Methodology | Full Text
![Illustration of the design and analysis of a crossover trial. Carryover... | Download Scientific Diagram Illustration of the design and analysis of a crossover trial. Carryover... | Download Scientific Diagram](https://www.researchgate.net/profile/Kay-Dickersin/publication/281173748/figure/fig7/AS:341492884361221@1458429656205/Illustration-of-the-design-and-analysis-of-a-crossover-trial-Carryover-effect-If-A-is_Q640.jpg)
Illustration of the design and analysis of a crossover trial. Carryover... | Download Scientific Diagram
![Statistical controversies in clinical research: limitations of open-label studies assessing antiangiogenic therapies with regard to evaluation of vascular adverse drug events—a meta-analysis - Annals of Oncology Statistical controversies in clinical research: limitations of open-label studies assessing antiangiogenic therapies with regard to evaluation of vascular adverse drug events—a meta-analysis - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/4ba8a139-a98a-4306-9ae7-443a9ad74d47/gr1_lrg.jpg)
Statistical controversies in clinical research: limitations of open-label studies assessing antiangiogenic therapies with regard to evaluation of vascular adverse drug events—a meta-analysis - Annals of Oncology
![Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension | Nature Medicine Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension | Nature Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41591-020-1034-x/MediaObjects/41591_2020_1034_Fig1_HTML.png)
Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension | Nature Medicine
![Testing for carryover effects after cessation of treatments: a design approach | BMC Medical Research Methodology | Full Text Testing for carryover effects after cessation of treatments: a design approach | BMC Medical Research Methodology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12874-016-0191-6/MediaObjects/12874_2016_191_Fig1_HTML.gif)
Testing for carryover effects after cessation of treatments: a design approach | BMC Medical Research Methodology | Full Text
![Illustration of the design and analysis of a crossover trial. Carryover... | Download Scientific Diagram Illustration of the design and analysis of a crossover trial. Carryover... | Download Scientific Diagram](https://www.researchgate.net/profile/Kay-Dickersin/publication/281173748/figure/fig2/AS:339910956470278@1458052495701/Reported-design-characteristics-of-included-crossover-trials-n-83_Q320.jpg)